Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Mar 2023 |
|---|---|---|---|---|
| Total reported revenue | — | 1.4B | 1.1B | — |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | — | — | — | — |
| Tax provision | — | — | — | — |
| Net income | — | — | — | — |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | 2.6B | — | — | 315.6M |
| Diluted average shares | 2.6B | — | — | 315.6M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |